Hecht Beth — SEC Form 4 filings
SEC reporting owner CIK 1652410. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-31 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 12 filings — 223,334 shares, $1,522,823 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 40,000 shares @ $5.43 ($217,244) in Xeris Biopharma Holdings, Inc., filed 2025-03-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | 16 | — | 13 legs · 223,334 sh · $1,522,823 | 19 |
Form 4 filings — Hecht Beth
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,666 @ $8.49 | EDGAR |
| 2026-08-04 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,666 @ $8.01 | EDGAR |
| 2026-07-02 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,666 @ $8.03 | EDGAR |
| 2026-06-02 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,667 @ $6.06 | EDGAR |
| 2026-05-01 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,667 @ $6.23 | EDGAR |
| 2026-04-03 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,667 @ $5.99 | EDGAR |
| 2026-03-04 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,567 @ $6.24 · Sale (S): 100 @ $7.06 | EDGAR |
| 2026-02-02 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 121,293 @ $0 · Tax withholding (F): 98,375 @ $7.36 · Tax withholding (F): 46,914 @ $7.36 · Tax withholding (F): 24,266 @ $7.36 · Sale (S): 16,667 @ $7.45 · Grant/award (A): 162,162 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,667 @ $7.43 | EDGAR |
| 2025-12-02 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,667 @ $7.01 | EDGAR |
| 2025-11-13 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 16,667 @ $7.40 | EDGAR |
| 2025-03-21 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Sale (S): 40,000 @ $5.43 | EDGAR |
| 2025-02-03 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 45,909 @ $3.56 · Tax withholding (F): 98,375 @ $3.56 · Grant/award (A): 185,000 @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 32,039 @ $3.61 | EDGAR |
| 2024-08-09 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Tax withholding (F): 14,037 @ $2.11 · Tax withholding (F): 4,448 @ $2.11 · Tax withholding (F): 33,488 @ $1.12 · Tax withholding (F): 21,177 @ $1.26 · Tax withholding (F): 5,784 @ $1.24 · Tax withholding (F): 33,488 @ $2.24 · +2 more | EDGAR |
| 2024-01-31 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 750,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1652410 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →